Comunicati Stampa
Salute e Benessere

Backed by $2 Million, Droplet IV is Set to Launch its Revolutionary Automatic IV-Line Flushing Device in EU & US in 2026

"The clinical relevance of Droplet IV's technology is clear," said John Lindskog, former executive of ConvaTec and Cimon Medical. "It fills a critical gap in IV medication safety and efficiency - a long-overdue solution for hospitals worldwide." "The clinical relevance of Droplet IV's technology is clear," saidJohn Lindskog, former executive of ConvaTec and Cimon Medical. "It fills a critical gap in IV medication safety and efficiency - a long-overdue solution for hospitals worldwide...
COPENHAGEN, Denmark, (informazione.news - comunicati stampa - salute e benessere)

"The clinical relevance of Droplet IV's technology is clear," said John Lindskog , former executive of ConvaTec and Cimon Medical. "It fills a critical gap in IV medication safety and efficiency - a long-overdue solution for hospitals worldwide."

Droplet IV's total funding now exceeds $5 million , including more than $3 million in non-dilutive grants and previous funding from the BioInnovation Institute, Europe's leading life science accelerator.

The company now has the capital needed to complete its final regulatory and clinical milestones and commercial launch the product in both the European and U.S. markets by 2026.

"We get inquiries from nurses regularly asking when they can have the product" said Marcus Bech , CEO of Droplet IV. "This funding will enable us to make it available to our customers already next year, and I am I'm incredibly proud to have attracted investors with such deep expertise and commitment to help us fulfill this mission"

Automated IV flushing is gaining increased recognition in clinical settings - especially in areas where accurate medication dosing is critical. Yet no streamlined, automatic solutions currently exist. Nurses are often burdened with time-consuming manual flushing procedures that introduce variability and increase the risk of error.

"I'm excited to see Droplet IV speeding up access to this much-needed technology," said Lisa Gorski , a leading U.S.-based Key Opinion Leader (KOL) in IV therapy and Clinical Advisor to Droplet IV. "Nurses need simple, reliable tools to ensure safe and consistent flushing without it becoming a daily burden."

The strength of the investor group speaks to both the market's unmet need and the innovation behind Droplet IV's platform.

www.DropletIV.com

Photo - https://mma.prnewswire.com/media/2713989/Droplet_IV_Founding_Team.jpg
Logo - https://mma.prnewswire.com/media/2714148/Droplet_IV_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/backed-by-2-million-droplet-iv-is-set-to-launch-its-revolutionary-automatic-iv-line-flushing-device-in-eu--us-in-2026-302485390.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili